S. Welten

607 total citations
13 papers, 508 citations indexed

About

S. Welten is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, S. Welten has authored 13 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in S. Welten's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (4 papers). S. Welten is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (4 papers). S. Welten collaborates with scholars based in Netherlands, United States and Denmark. S. Welten's co-authors include Paul H.A. Quax, A. Yaël Nossent, Margreet R. de Vries, Erna A Peters, A.J.N.M. Bastiaansen, Martin C. Boonstra, Rob C. M. de Jong, Søren P. Sheikh, Ekambar R. Kandimalla and Nicola La Monica and has published in prestigious journals such as PLoS ONE, Circulation Research and Annals of Surgery.

In The Last Decade

S. Welten

13 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Welten Netherlands 11 393 285 76 74 47 13 508
Shao-Guang Sun China 12 509 1.3× 347 1.2× 81 1.1× 40 0.5× 49 1.0× 28 653
A.J.N.M. Bastiaansen Netherlands 10 282 0.7× 121 0.4× 105 1.4× 118 1.6× 36 0.8× 11 433
Linka Xie China 11 360 0.9× 149 0.5× 71 0.9× 38 0.5× 47 1.0× 17 533
Yongri Ouyang China 12 314 0.8× 256 0.9× 115 1.5× 53 0.7× 52 1.1× 25 599
Cheng-Chung Cheng Taiwan 8 252 0.6× 143 0.5× 44 0.6× 46 0.6× 23 0.5× 9 376
Rachel Simmons United States 6 243 0.6× 167 0.6× 83 1.1× 45 0.6× 45 1.0× 6 396
Yifeng Cui China 9 311 0.8× 281 1.0× 37 0.5× 69 0.9× 67 1.4× 20 494
Shaojian Lin China 15 358 0.9× 250 0.9× 112 1.5× 87 1.2× 75 1.6× 35 641

Countries citing papers authored by S. Welten

Since Specialization
Citations

This map shows the geographic impact of S. Welten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Welten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Welten more than expected).

Fields of papers citing papers by S. Welten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Welten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Welten. The network helps show where S. Welten may publish in the future.

Co-authorship network of co-authors of S. Welten

This figure shows the co-authorship network connecting the top 25 collaborators of S. Welten. A scholar is included among the top collaborators of S. Welten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Welten. S. Welten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Welten, S., et al.. (2018). Posttranscriptional Regulation of 14q32 MicroRNAs by the CIRBP and HADHB during Vascular Regeneration after Ischemia. Molecular Therapy — Nucleic Acids. 14. 329–338. 22 indexed citations
2.
Welten, S., Margreet R. de Vries, Erna A Peters, et al.. (2017). Inhibition of Mef2a Enhances Neovascularization via Post-transcriptional Regulation of 14q32 MicroRNAs miR-329 and miR-494. Molecular Therapy — Nucleic Acids. 7. 61–70. 15 indexed citations
3.
Welten, S., Rob C. M. de Jong, Anouk Wezel, et al.. (2017). Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis. Atherosclerosis. 261. 26–36. 29 indexed citations
4.
Nossent, A. Yaël, A.J.N.M. Bastiaansen, Erna A Peters, et al.. (2017). CCR7‐CCL19/CCL21 Axis is Essential for Effective Arteriogenesis in a Murine Model of Hindlimb Ischemia. Journal of the American Heart Association. 6(3). 28 indexed citations
5.
Welten, S., et al.. (2016). The multifactorial nature of microRNAs in vascular remodelling. Cardiovascular Research. 110(1). 6–22. 110 indexed citations
6.
Welten, S., Ming Tao, Alban Longchamp, et al.. (2016). Upregulation of 14q32 microRNAs in Human Subcutaneous Adipose Tissue of Patients with Critical Limb Ischemia at Risk of Major Amputation. European Journal of Vascular and Endovascular Surgery. 52(3). 409–409. 1 indexed citations
7.
Wezel, Anouk, et al.. (2016). Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability. Journal of Vascular Surgery. 63(3). 845–845. 3 indexed citations
8.
Wezel, Anouk, S. Welten, H. Maxime Lagraauw, et al.. (2015). Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability. Annals of Surgery. 262(5). 841–848. 39 indexed citations
9.
Bastiaansen, A.J.N.M., Jacco C. Karper, Anouk Wezel, et al.. (2014). TLR4 Accessory Molecule RP105 (CD180) Regulates Monocyte-Driven Arteriogenesis in a Murine Hind Limb Ischemia Model. PLoS ONE. 9(6). e99882–e99882. 22 indexed citations
10.
Welten, S., A.J.N.M. Bastiaansen, Rob C. M. de Jong, et al.. (2014). Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia. Circulation Research. 115(8). 696–708. 123 indexed citations
11.
Bastiaansen, A.J.N.M., M.M. Ewing, Hetty C. de Boer, et al.. (2013). Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 33(8). 1902–1910. 51 indexed citations
12.
Nossent, A. Yaël, Tilde Eskildsen, Peter Bie, et al.. (2013). The 14q32 MicroRNA-487b Targets the Antiapoptotic Insulin Receptor Substrate 1 in Hypertension-Induced Remodeling of the Aorta. Annals of Surgery. 258(5). 743–753. 35 indexed citations
13.
Oleaga, Carlota, S. Welten, Anna Solé, et al.. (2012). Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics. Biochemical Pharmacology. 84(12). 1581–1591. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shao-Guang Sun Breakdown of academic impact, for papers by A.J.N.M. Bastiaansen Breakdown of academic impact, for papers by Linka Xie Breakdown of academic impact, for papers by Yongri Ouyang Breakdown of academic impact, for papers by Cheng-Chung Cheng Breakdown of academic impact, for papers by Rachel Simmons Breakdown of academic impact, for papers by Yifeng Cui Breakdown of academic impact, for papers by Shaojian Lin
Rankless by CCL
2026